Margherita Bonferroni

In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity.

Maria Teresa Fierro, Xinsheng Liao, Paolo Lusso et al. · PubMed · 1988 · 94 citations

Life Sciences, Immunology, Oncology +9

Interleukin 2 does not promote the <i>in vitro</i> and <i>in vivo</i> proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin

Robin Foà, Patrizia Caretto, Maria Teresa Fierro et al. · British Journal of Haematology · 1990 · 51 citations

Medicine, Hematology, Immunology +10

Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors

R. Foà, Mt Fierro, Donatella Raspadori et al. · Blood · 1990 · 35 citations · Full text

Life Sciences, Hematology, Immunology +9

Treatment of hairy-cell leukaemia with α-interferon (α-IFN)

F. Lauria, Robin Foà, Donatella Raspadori et al. · European Journal of Cancer and Clinical Oncology · 1988 · 28 citations

Medicine, Hematology, Immunology +8

Lymphokine‐activated killer (LAK) cells inhibit the clonogenic growth of human leukemic stem cells

Patrizia Lista, Maria Teresa Fierro, Xinsheng Liao et al. · European Journal Of Haematology · 1989 · 25 citations

Medicine, Hematology, Oncology +8